论文部分内容阅读
目的探讨单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗子宫腺肌病临床效果。方法选取本院2009年1月~2012年12月160例子宫腺肌病患者,按照自愿原则分为研究组和对照组,对照组患者应用单纯子宫腺肌病病灶切除术进行治疗,研究组则在此基础上予以促性腺激素释放激素激动剂进行治疗,分析比较两组患者治疗效果。结果两组患者治疗后痛经评分(VAS)明显降低,经量减少,两组差异具有统计学意义(P<0.05);研究组痛经有效率高于对照组,且不易复发,差异具有统计学意义(P<0.05)。结论单纯子宫腺肌病病灶切除术后联合促性腺激素释放激素激动剂治疗子宫腺肌病效果明显,复发率下降,具有较高临床推广应用价值。
Objective To investigate the clinical efficacy of combined gonadotropin-releasing hormone agonist in the treatment of adenomyosis after focal resection of adenomyosis. Methods A total of 160 cases of adenomyosis from January 2009 to December 2012 in our hospital were divided into study group and control group according to the principle of voluntariness. Patients in control group were treated with resection of adenomyosis alone. On the basis of gonadotropin-releasing hormone agonist for treatment, analysis and treatment of two groups of patients. Results After treatment, the dysmenorrhea score (VAS) was significantly decreased and the volume decreased in both groups (P <0.05). The effective rate of dysmenorrhea in the study group was higher than that of the control group, and the recurrence rate was not significant (P <0.05). Conclusion Adenomyosis alone after resection combined with gonadotropin-releasing hormone agonist treatment of adenomyosis effect is obvious, the recurrence rate decreased, with high clinical value.